Runsewe Oluwapeyibomi I, Srivastava Sunil K, Sharma Sumit, Chaudhury Pulkit, Tang W H Wilson
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States of America.
Cole Eye Institute, Cleveland Clinic, Cleveland, OH, United States of America.
Prog Cardiovasc Dis. 2024 Nov-Dec;87:60-72. doi: 10.1016/j.pcad.2024.10.011. Epub 2024 Oct 21.
Endothelial dysfunction and microvascular remodeling underly the development and progression of a host of cardiovascular disease (CVD). However, current methods to assess coronary epicardial microvascular function are invasive, time-intensive, and costly. Optical coherence tomography angiography (OCTA) is an established technology within ophthalmology that provides a quick, noninvasive assessment of vascular structures within the retina. As a growing body of evidence reveals strong associations between the retinal changes on OCTA and the development and progression of CVD, OCTA may indeed be a surrogate test for end-organ dysfunction. OCTA has potential to enhance diagnostic performance, refine cardiovascular risk assessment, strengthen prognostication, and ultimately, improve patient care. We explore the current literature on OCTA in cardiovascular diseases to summarize the clinical utility of retinal OCTA imaging and discuss next-generation cardiovascular applications.
内皮功能障碍和微血管重塑是许多心血管疾病(CVD)发生和发展的基础。然而,目前评估冠状动脉心外膜微血管功能的方法具有侵入性、耗时且成本高的特点。光学相干断层扫描血管造影(OCTA)是眼科领域的一项成熟技术,可对视网膜内的血管结构进行快速、无创评估。随着越来越多的证据表明OCTA上的视网膜变化与CVD的发生和发展之间存在密切关联,OCTA可能确实是一种用于评估终末器官功能障碍的替代检测方法。OCTA有潜力提高诊断性能、优化心血管风险评估、加强预后判断,并最终改善患者护理。我们探讨了当前关于OCTA在心血管疾病中的文献,以总结视网膜OCTA成像的临床应用价值,并讨论其在心血管领域的下一代应用。